London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production ...

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said ...

On a per-share basis, the Cambridge, Britain-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs, came to $1.24 per share. The results topped Wall Street ...

British pharmaceutical giant AstraZeneca reported a rise in first-quarter profit on Tuesday, driven by strong sales growth in ...

The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.

AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the ...

AstraZeneca posted increased core earnings per share and sales for the first quarter. The British pharmaceutical giant said Tuesday that its core earnings per share--the company's preferred metric, ...

AstraZeneca on Tuesday said it may face a fine of up to $8 million over suspected unpaid import taxes in China as the ...

AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today ...

AstraZeneca PLC closed 21.38% short of its 52-week high of £133.88, which the company achieved on September 3rd.